Anticholinergic evaluation of 1,1-diphenyl-2-(1-methyl-3-pyrrolidyl) ethanol and N-(2'5'-dimethyl-1'-piperidylmethyl) benzilamide.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D004158:Diphenylacetic Acids / Q000494:pharmacology; D004336:Drug Antagonism; D066298:In Vitro Techniques; D007583:Jejunum; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects*; D014282:Trihexyphenidyl / Q000494:pharmacology
D004158:Diphenylacetic Acids; D010276:Parasympatholytics; D014282:Trihexyphenidyl; D001285:Atropine; D010208:Papaverine; D012601:Scopolamine